Misonix to Participate at Upcoming Investor Conferences

Rhea-AI Summary

On February 11, 2021, Misonix (NASDAQ: MSON) announced CEO Stavros Vizirgianakis and CFO Joe Dwyer will participate in two investor conferences. The BTIG Virtual MedTech Conference is scheduled for February 17-18, with Misonix presenting on February 17 at 2:00 p.m. EST. The 10th Annual SVB Leerink Global Healthcare Conference will take place on February 24-26, featuring a fireside chat on February 26 at 8:00 a.m. EST. Investors can arrange one-on-one meetings through conference representatives or contact Misonix's investor relations for more details.

FARMINGDALE, N.Y., Feb. 11, 2021 (GLOBE NEWSWIRE) -- Misonix, Inc. (NASDAQ: MSON), a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative products that enhance clinical outcomes, today announced that Misonix Chief Executive Officer, Stavros Vizirgianakis, along with Joe Dwyer, Chief Financial Officer, will be participating in two upcoming investor conferences.

• BTIG Virtual MedTech, Digital Health, Life Science & Diagnostics Tools Conference
  Dates: February 17^th and 18^th
  Management will host a presentation on Wednesday, February 17^th at 2:00 p.m. EST

• 10^th Annual SVB Leerink Global Healthcare Conference
  Dates: February 24^th, 25^th and 26^th
  Management will host a fireside chat on Friday, February 26^th at 8:00 a.m. EST

For more information about the conferences or to schedule a virtual one-on-one meeting with management, please contact your conference representative. Alternatively, please contact Misonix’s investor relations at mson@jcir.com.

About Misonix, Inc.
Misonix, Inc. (Nasdaq: MSON) is a provider of minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products. Its surgical team markets and sells BoneScalpel and SonaStar, which facilitate precise bone sculpting and removal of soft and hard tumors and tissue, primarily in the areas of neurosurgery, orthopedic, plastic and maxillo-facial surgery. The Company's wound team markets and sells TheraSkin, Therion, TheraGenesis and SonicOne to debride, treat and heal chronic and traumatic wounds in inpatient, outpatient and physician office sites of service. At Misonix, Better Matters! That is why throughout the Company’s history, Misonix has maintained its commitment to medical technology innovation and the development of products that radically improve outcomes for patients. Additional information is available on the Company's web site at www.misonix.com.

Contact:
Joe Dwyer	Norberto Aja, Jennifer Neuman
Chief Financial Officer	JCIR
Misonix, Inc.	212-835-8500 or mson@jcir.com
631-927-9113

FAQ

What is Misonix's upcoming event schedule in February 2021?

Misonix will participate in the BTIG Virtual MedTech Conference on February 17-18 and the 10th Annual SVB Leerink Global Healthcare Conference on February 24-26.

When will Misonix present at the BTIG Virtual MedTech Conference?

Misonix will present on February 17 at 2:00 p.m. EST during the BTIG Virtual MedTech Conference.

What time is Misonix's fireside chat at the SVB Leerink Global Healthcare Conference?

The fireside chat for Misonix at the SVB Leerink Global Healthcare Conference is scheduled for February 26 at 8:00 a.m. EST.

How can investors schedule a one-on-one meeting with Misonix management?

Investors can schedule a virtual one-on-one meeting by contacting their conference representative or reaching out to Misonix’s investor relations.

What products does Misonix provide in the medical technology sector?

Misonix offers minimally invasive therapeutic ultrasonic medical devices and regenerative tissue products for various surgical applications.